Ausdal Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-485
| Closed | -$253K | – | 463 |
|
|
2023
Q2 | $253K | Sell |
485
-24
| -5% | -$12.5K | 0.03% | 356 |
|
|
2023
Q1 | $293K | Buy |
509
+32
| +7% | +$18.4K | 0.04% | 353 |
|
|
2022
Q4 | $262K | Sell |
477
-64
| -12% | -$35.2K | 0.04% | 370 |
|
|
2022
Q3 | $275K | Buy |
541
+10
| +2% | +$5.08K | 0.04% | 349 |
|
|
2022
Q2 | $289K | Sell |
531
-5
| -0.9% | -$2.72K | 0.04% | 347 |
|
|
2022
Q1 | $317K | Buy |
536
+24
| +5% | +$14.2K | 0.04% | 363 |
|
|
2021
Q4 | $342K | Sell |
512
-21
| -4% | -$14K | 0.05% | 350 |
|
|
2021
Q3 | $305K | Buy |
533
+47
| +10% | +$26.9K | 0.05% | 358 |
|
|
2021
Q2 | $245K | Sell |
486
-10
| -2% | -$5.04K | 0.04% | 386 |
|
|
2021
Q1 | $226K | Buy |
496
+4
| +0.8% | +$1.82K | 0.04% | 394 |
|
|
2020
Q4 | $229K | Buy |
492
+4
| +0.8% | +$1.86K | 0.04% | 369 |
|
|
2020
Q3 | $216K | Buy |
+488
| New | +$216K | 0.05% | 320 |
|
|
2020
Q2 | – | Sell |
-626
| Closed | -$205K | – | 309 |
|
|
2020
Q1 | $205K | Buy |
+626
| New | +$205K | 0.07% | 251 |
|
|
2016
Q1 | – | Sell |
-60
| Closed | -$9K | – | 943 |
|
|
2015
Q4 | $9K | Buy |
+60
| New | +$9K | ﹤0.01% | 944 |
|